CD4 and inflammatory bowel disease: These miRNAs have been studied in CD4+ T cells [18], but minimally in the effector roles of CD8+ T lymphocytes in inflammatory bowel disease, though increasingly, evidence suggests that miR‐29a/b have a significant regulatory role in CD8+ T cells' memory capacity.